Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease)

Scandinavian Journal of Immunology

Volumn 48, Issue 5, 1998, Pages 544-550

  Halacheva, K S ^a,b   Manolova, I M ^a   Petkov, D P ^a   Andreev, A P ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN; ELASTASE; LACTOFERRIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; BUERGER DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GRANULOMA; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; NEUTROPHILS; PANCREATIC ELASTASE; PEROXIDASE; THROMBOANGIITIS OBLITERANS;

EID: 0031762454     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shionoya S. What is Buerger's disease? World J Surg 1983;7:544-51.
2. Gulati S, Madhra K, Thusoo TK et al. Autoantibodies in Thromboangiitis obliterans (Buerger's disease). Angiol 1982;33:642-51.
3. Adar R, Papa MZ, Halpern Z et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983;308:1113-6.
4. Hada M, Sakihama T, Kamiya K, Tasaka K, Ueno A. Cellular and humoral immune responses to vascular components in thromboangiitis obliterans. Angiol 1993;44:533-40.
5. Shellong SM, Rantmann A, Gross WL, Alexander K. No ANCA in thromboangiitis obliterans (Buerger's disease). Adv Exp Med Biol 1993;336:327-30.
6. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
7. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Stand 1989;97 (Suppl. 6):12-3.
8. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: Immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1-12.
9. Saxon A, Shanahan F, Lander C, Ganz T, Targan SR. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
10. Esnault VLM, Short AK, Audrain MAP et al. Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays. Kidney Int 1994;46:153-60.
11. Hagen EC, Andrassy K, Csernok E et al. Development and standardization of solid phase assays for detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standartization of ANCA assay. J Immunol Meth 1996;196:1-15.
12. Ludemann J, Utrecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-62.
13. Nolle B, Specks V, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
14. Cohen Tervaert JW, Goldschmeding R, Elema JD et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990;33:1264-72.
15. Cohen Tervaert JW, van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5.
16. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol, 1989;135:921-30.
17. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: charactaristization and clinical corelations. Arthritis Rheum 1993; 36:1054-60.
18. Manolova I, Altunkova I, Michailova D. A study of anti-neutrophil cytoplasmic antibodies (ANCA) in patients with juvenile chronic arthritis. Med Sci Res 1996;24:111-2.
19. Rump JA, Scholmerich J, Gross V et al. A new type of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol 1990;181:406-13.
20. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver disease. Hepatol 1993; 17:411-7.
21. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
22. Sinico RA, Pozzi C, Radice A et al. Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases. Am J Kidney Dis 1993;22:253-69.
23. Cohen Tervaert JW, Mulder AHL, Stegeman CA et al. Occurrence of autoantibodies to human leukocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52:115-20.
24. Schnabel A, Hauschild S, Gross WL. Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Immunol 1996;109:201-6.
25. Falk RJ, Terrell RS, Charles LA, Jennette JC. Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
26. Savage COS, Pottinger BE, Gaskin G, Pisey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-42.
27. Yang JJ, Kettritz R, Falk RJ, Jennette JC, Gaido ML. Apoptosis of endothelial cells induced by neutrophil serine proteases Proteinase 3 and Elastase. Am J Pathol 1996;149:1617-25.